U.S. Markets open in 39 hrs, 55 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 8,280.74 | -223.32 | -2.63% |
| NASDAQ | 1,796.52 | -49.20 | -2.67% |
| S&P 500 | 896.42 | -26.91 | -2.91% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 10.00 10:09 AM EDT | |
|---|---|---|
| Day High | 10.43 09:30 AM EDT |
|
| Range | 0.43 |
| Volume | 146,278 | |
|---|---|---|
| 30-Day Avg Vol | 250,000 |
|
| Difference | -41.49% |
| Market Cap | 517.14 M | |
|---|---|---|
| Mkt Cap Chg | 1.00 M |
| Shares Out | 50.40 M | |
|---|---|---|
| % Shrs Traded | 0.29% | |
| 1yr EPS Est | -0.93 |
| 52-Wk Low | 4.39 12/16/08 | |
|---|---|---|
| 52-Wk High | 12.01 7/31/08 |
|
| Range | 7.62 |
| Prev Close | 10.24 7/1/09 | |
|---|---|---|
| Today's Open | 10.37 | |
| Change | 1.27% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 4.3 M |
| Revenue (LFY) | 0 | |
|---|---|---|
| Earnings (LFY) | -57.10 M | |
| Earnings (MRQ) | -10.44 M | |
| Next Earn Est | -0.214 | |
| Next Earnings | 08/07/2009 |
|
| EPS (TTM) | -1.38 | |
| 1yr EPS Growth | 32.61% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -11.00 | |
| PEG Ratio | — | |
| Return on Equity | -186.00 | |
| Beta | — |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Cadence Pharmaceuticals follows the rhythm of hospitals' medical needs. The biopharmaceutical company develops drug candidates primarily for use in a hospital setting. The company licenses rights to compounds ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.214 8/7/09 | — — |
—
—
|
| Last Quarter | -0.24 3/31/09 | -0.24 3/31/09 |
0.00
Met
|
| 2 Quarters Ago | -0.363 12/31/08 | -0.37 12/31/08 |
-0.007
Missed
|
| Quarterly - 03/31/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 0.00 | 0.00 |
| Gross Profit | — | -529,646.00 |
| Operating Income | -10.14 M | -54.15 M |
| Net Income | -10.44 M | -57.10 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts